Myocardial infarction (MI), commonly known as a heart attack, is a life-altering cardiovascular event with immediate physical consequences, but its psychological impacts can be equally profound and enduring. Patients who experience MI frequently report elevated perceived stress and heightened death anxiety—a psychological state characterized by intense fear or apprehension related to mortality. These mental burdens can exacerbate physiological recovery and complicate adherence to medical regimens, making their management a critical aspect of comprehensive cardiac care.

Perceived stress refers to individuals’ subjective evaluation of stressors in their environment and their ability to cope with these demands. In the context of MI survivors, persistent perceived stress often emanates from concerns about health, physical limitations, and the looming possibility of recurrent cardiac events. Such psychological distress does not function in isolation but interplays dynamically with death anxiety, where the trauma of a near-fatal episode forces a confrontation with mortality, intensifying emotional turmoil.

The novel research focuses on an intermediary psychological construct termed self-transcendence—a concept rooted in positive psychology and spirituality, involving the ability to transcend personal limitations and connect with meanings greater than oneself. Self-transcendence may serve as a buffer or mediator, potentially alleviating the negative emotional impacts of stress and death anxiety, thus promoting psychological adaptation and improved coping strategies in vulnerable populations like elderly MI patients.

Utilizing sophisticated psychometric assessments and rigorous statistical analyses, the researchers delved into this triadic relationship, elucidating how self-transcendence mediates the link between perceived stress and death anxiety. Their findings indicate that individuals exhibiting higher levels of self-transcendence show a marked reduction in the psychological burden associated with stress and fear of death. This suggests that fostering self-transcendent experiences might be key to enhancing mental well-being post-MI.

The study offers compelling evidence that self-transcendence promotes reframing of stressful experiences and existential fears into opportunities for personal growth, spiritual exploration, or a reaffirmation of one’s legacy and purpose beyond physical health constraints. This reframing could fundamentally alter the trajectory of psychological recovery, changing the way patients interpret their cardiac event from one of vulnerability to a catalyst for meaningful transformation.

Beyond theoretical implications, this research provides actionable insights for healthcare providers. Integrative care models incorporating self-transcendence-enhancing interventions—such as mindfulness training, narrative therapy, or spiritually oriented counseling—may significantly improve patients’ psychological outcomes. The emphasis on self-transcendence aligns with holistic treatment approaches that recognize the inseparability of mind and body in healing processes.

Moreover, the research underscores the importance of detecting elevated perceived stress and death anxiety promptly in post-MI care settings. Early psychological screening and targeted interventions could prevent the entrenchment of debilitating emotional states that impede cardiac rehabilitation. Personalized therapeutic strategies, incorporating the nuances uncovered in this study, could revolutionize patient engagement and compliance.

The implications extend as well to public health strategies aimed at aging populations who face increasing incidences of myocardial infarctions globally. Understanding how psychological resilience factors like self-transcendence modulate stress and anxiety responses offers pathways to bolster population-level mental health, potentially reducing morbidity and healthcare costs associated with poor psychological adjustment after cardiac events.

On a neurobiological level, the interplay among these psychological variables invites further exploration of the biomarkers linked to stress responses, neural correlates of death anxiety, and the neuroplastic effects of self-transcendence-oriented practices. Elucidating brain mechanisms underlying these phenomena could facilitate development of precision mental health interventions tailored to neurocognitive profiles of older cardiac patients.

This comprehensive study also invites interdisciplinary dialogue among cardiologists, psychologists, gerontologists, and spiritual care providers. The integration of knowledge across these domains will be necessary to design multifaceted treatment plans addressing the complex interdependencies of physical illness and emotional well-being, particularly in populations vulnerable to existential distress.

Furthermore, the findings encourage reevaluation of patient education frameworks. Empowering patients with knowledge about the psychological dimensions of recovery, alongside pharmacological and lifestyle therapies, could enhance self-management competencies. Emphasizing the cultivation of self-transcendence through psychosocial resources might foster resilience that persists well beyond hospital discharge.

While the research provides a robust foundation, it also signals areas requiring deeper investigation. Longitudinal studies tracking the dynamic evolution of perceived stress, death anxiety, and self-transcendence throughout the recovery timeline could clarify causality and temporal patterns. Additionally, examining cultural, spiritual, and individual differences in self-transcendent capacity may optimize personalized care approaches.

The nexus of myocardial infarction, psychological distress, and transcendental coping strategies illuminated by this study marks a paradigm shift in addressing the intangible dimensions of cardiac rehabilitation. By moving beyond symptom management toward fostering holistic resilience, the medical community can better support aging patients in reclaiming agency, meaning, and hope amidst life-threatening challenges.

As mental health continues to gain recognition as integral to overall health, this study’s revelations resonate globally, especially amidst rising cardiovascular disease burdens paired with increasing mental health challenges. The mediating role of self-transcendence offers a beacon for future intervention research, clinical innovation, and policy development focused on enhancing quality of life for millions worldwide confronting the aftermath of myocardial infarction.

Ultimately, this research heralds a new era in which the psychological aftermath of heart disease is not viewed as an unfortunate side effect but as a critical domain ripe for therapeutic engagement and transformation. This vision aligns with emerging holistic healthcare philosophies emphasizing interconnectedness of mind, body, and spirit in healing.

In clinical practice, adopting assessment tools for perceived stress and death anxiety, alongside interventions fostering self-transcendence, could become standard components of cardiovascular care protocols. Such integration promises to close gaps between physical recovery and psychological health, reflecting a truly patient-centered model of care.

This innovative research, published in BMC Psychology in 2025, charts a promising path toward mitigating the psychosocial challenges faced by older adults post-myocardial infarction, offering hope for improved mental resilience and enhanced life satisfaction amid the vulnerability of aging and chronic illness.

As the medical research community builds on these insights, patients, caregivers, and clinicians alike may soon benefit from more effective strategies that honor the full complexity of human experience following critical health crises.

Subject of Research: The study investigates the relationship between perceived stress and death anxiety, with a focus on the mediating role of self-transcendence among elderly patients who have experienced myocardial infarction.

Article Title: Relationship between perceived stress and death anxiety with mediating role of self-transcendence among older patients with myocardial infarction.

Article References: Hosseini, S.M., Mohammadi, F., Hosseinkhani, Z. et al. Relationship between perceived stress and death anxiety with mediating role of self-transcendence among older patients with myocardial infarction. BMC Psychol (2025). https://doi.org/10.1186/s40359-025-03897-1

Image Credits: AI Generated

Cardiometabolic diseases, encompassing conditions such as hypertension, diabetes mellitus, and dyslipidemia, are leading causes of morbidity worldwide. These conditions not only arise from genetic and metabolic disturbances but are also significantly influenced by psychological factors like stress, depression, and anxiety. CBT, long a staple in managing psychological disorders, is increasingly investigated for its potential to disrupt the complex bidirectional pathways linking mental health to cardiovascular and metabolic abnormalities.

The meta-review spans literature published between 2010 and 2024, analyzing sixteen meta-analyses that examined CBT’s effectiveness in populations characterized by cardiometabolic abnormalities. This layered approach—systematically reviewing multiple meta-analyses—affords an expansive and critical perspective on the evidence base, moving beyond isolated studies to assess reproducibility, overall trends, and methodological quality.

One of the clearest outcomes from this comprehensive review is CBT’s consistent efficacy in alleviating depressive symptoms and anxiety among patients with cardiometabolic risks. Psychological distress frequently exacerbates cardiometabolic disease progression through neuroendocrine disruptions, unhealthy lifestyle choices, and poor treatment adherence. By mitigating these mental health burdens, CBT may indirectly influence physiological pathways, underscoring the synergy between mind and body in disease management.

However, when it comes to the direct modification of cardiometabolic risk markers such as blood pressure, lipid profiles, and glycemic control, the evidence remains inconclusive and at times contradictory. While some studies within the meta-analyses reported modest improvements, others failed to demonstrate significant changes, reflecting heterogeneity in study designs, intervention intensity, patient populations, and outcome measures. Such variability challenges the derivation of definitive conclusions and signals a need for harmonized research standards.

Quality of life, a crucial patient-centered outcome, also presents mixed findings. Although CBT’s potential to enhance psychological well-being is established, its direct translation to improved overall quality of life in cardiometabolic patients appears less certain. This might reflect the multifaceted nature of quality of life, influenced by physical symptoms, social determinants, and chronic disease burden, demanding more integrative therapeutic models.

Another critical implication of CBT in cardiometabolic care concerns the reduction of recurrent cardiovascular events. Cardiometabolic diseases often follow a chronic, relapsing-remitting course, and preventing subsequent episodes is a principal goal. The meta-review indicates a scarcity of high-quality data assessing whether CBT contributes to lowering such event recurrence, representing a gap in current clinical evidence and a fertile area for prospective longitudinal studies.

Methodological shortcomings present a recurring theme across the evaluated literature. Many included meta-analyses feature small participant cohorts, varying CBT protocols, short follow-up durations, and inconsistencies in measuring outcomes. Additionally, high heterogeneity and moderate-to-low quality ratings call for cautious interpretation of reported findings. Robust, large-scale randomized controlled trials are paramount to elucidate the true impact and mechanisms of CBT in this context.

From a mechanistic standpoint, CBT’s potential influences revolve around behavioral modification and psychophysiological regulation. By fostering healthier lifestyle habits—such as increased physical activity, smoking cessation, and dietary compliance—CBT may indirectly improve cardiometabolic markers. Concurrently, attenuating chronic stress responses via cognitive restructuring and emotional regulation might modulate autonomic nervous system imbalances implicated in hypertension and metabolic dysregulation.

Integrative treatment paradigms also emerge from this review’s insights. Combining CBT with pharmacotherapy and lifestyle interventions could synergistically optimize cardiometabolic risk management. Personalized approaches acknowledging individual psychological profiles, socioeconomic factors, and disease phenotypes are likely to enhance therapeutic efficacy.

While CBT’s promise is evident, translating these findings into routine clinical practice warrants overcoming practical barriers, including the availability of trained therapists, patient adherence, and healthcare system integration. Digital health innovations, such as internet-based CBT platforms and mobile apps, might democratize access and tailor interventions, representing the next frontier in behavioral cardiometabolic care.

In conclusion, this systematic meta-review of meta-analyses consolidates existing evidence positioning cognitive behavioral therapy as a valuable tool in addressing psychological factors intertwined with cardiometabolic disease. Yet, the landscape is nuanced, with mixed results in physiological risk marker improvements and quality of life gains. The study underscores the imperative for further rigorous research to validate and optimize CBT’s role, advocating a holistic approach that bridges mental and physical health to tackle these pervasive chronic diseases effectively.

As cardiometabolic diseases continue to dominate global health burdens, interdisciplinary research steering psychological interventions like CBT into mainstream preventative and therapeutic frameworks may redefine chronic disease management. This integration promises not only to improve clinical outcomes but also to enhance patient empowerment and quality of life, setting a new paradigm in contemporary medicine.

Subject of Research:
Cognitive behavioral therapy for the management of cardiometabolic disease risk factors.

Article Title:
Cognitive behavioral therapy for the management of cardiometabolic disease risk factors; a systematic meta-review of meta-analyses

Article References:
Baourda, V.C., Panagiotakos, D. Cognitive behavioral therapy for the management of cardiometabolic disease risk factors; a systematic meta-review of meta-analyses. BMC Psychiatry 25,